AST012 - Newly diagnosed asthma with tests

AST012 - Newly diagnosed asthma with tests

Info
The information contained within this article is from version 50 of the Business Rules for Quality and Outcomes Framework (QOF).                                                                                                   
Warning
The codes referenced in this article are taken from the NHS Technology Reference Update Distribution (TRUD).  Not all of these may be present or selectable in all clinical systems.                                                
Idea
This indicator was released in the contract year 2025/26 with version 50 of the Business Rules for QOF, replacing AST011                                                                                           

Indicator definition

Indicator ID

Description

AST012

The percentage of patients with a diagnosis of asthma on or after 1 April 20235 with a record of an objective test between 3 months before or 3 months after diagnosis.

How is this different to AST011?

The business rules have been updated to reflect the new NICE guidelines, removing the need for spirometry and including other diagnostic tests such as FBC blood test (for eosinophils), bronchial challenge tests and skin prick tests (for <16s only) as the diagnostic tests to diagnose asthma.  The diagnostic tests which count are different for patients over and under 16 years old.  The time period for the diagnostic tests to be done has been reduced from 6 months after diagnosis to 3 months after diagnosis.  You used to get a window for newly registered patients who were diagnosed before joining the practice in AST011 - this has been removed in AST012.

What do the business rules mean?

What makes a patient eligible?

In order to be included in the denominator (patients who are eligible for the indicator), patients must:
  1. be on the Asthma register
  2. have been diagnosed with asthma for the first time on or after 1st April 2025
Info
This backstop date tends to move forward every 2 years, meaning it isn't expected to change until at least 1st April 2027.

How to achieve the indicator

This depends on whether patients are under or over 16. 
Over 16
Patients must have had one of the following in the period spanning the 93 days (3 months) before or after the earliest unresolved asthma diagnosis
  1. a full blood count (for eosinophils)
  2. have a record of FeNO testing
  3. had a bronchodilator reversibility with spirometry (BDR) test
  4. had a peak expiratory flow rate (PEFR) variability test (if spirometry is not available)
  5. had a bronchial challenge test (codes currently unavailable)
Under 16
Patients must have had one of the following in the period spanning the 93 days (3 months) before or after the earliest unresolved asthma diagnosis
  1. have a record of FeNO testing
  2. had a bronchodilator reversibility with spirometry (BDR) test
  3. had a peak expiratory flow rate (PEFR) variability test (if spirometry is not available)
  4. had a skin prick test to house dust mite (codes currently unavailable)
  5. a total IgE level (codes currently unavailable) and blood eosinophil count
  6. had a bronchial challenge test (codes currently unavailable)

What will remove patients from eligibility?

  1. Patients from whom asthma quality indicator care was unsuitable in the contract year
  2. Patients who chose not to receive monitoring in the contract year
  3. Patients who have chosen not to receive any asthma quality indicator care in the contract year
  4. Patients who have been invited twice between 3 months before and 3 months after the asthma diagnosis
  5. Patients who were diagnosed in the last 3 months of the contract year
  6. Patients who were newly registered with the practice in the last 3 months of the contract year
If a patient achieves the indicator at any point during the year, any exclusions that have also been added are ignored.

SNOMED codes used in this indicator

WarningThe codes referenced in this article are taken from the NHS Technology Reference Update Distribution (TRUD).  Not all of these may be present or selectable in all clinical systems.

FBC codes (FBC_COD)

SNOMED code
SNOMED code description
1022431000000105
Haemoglobin estimation (observable entity)
1022451000000103
Red blood cell count (observable entity)
1022491000000106
Mean corpuscular volume (observable entity)
1022541000000102
Total white cell count (observable entity)
1107511000000100

Mass concentration of haemoglobin in blood (observable

entity)

1107531000000108
Substance concentration of haemoglobin in blood (observable entity)
1110441000000100
White blood cell count in blood (observable entity)
1491000237105
Mean corpuscular volume of erythrocytes in blood (observable entity)
375911000119106
Differential count of white blood cells by automated method (observable entity)

Codes indicating FeNO test performed (FENO_COD)

SNOMED code

SNOMED code description

1201788001

Volume fraction of nitric oxide in exhaled air

444642008Measurement of expired nitric oxide

Spirometry codes for asthma (ASTSPIR_COD)

SNOMED code

SNOMED code description

170627008

Airways obstruction reversible

314979004Spirometry reversibility test
314981002
Spirometry reversibility positive
391118006
Positive reversibility test to salbutamol
391119003
Positive reversibility test to ipratropium bromide
391121008
Positive reversibility test to a combination of salbutamol and ipratropium bromide
391122001
Positive reversibility test to corticosteroids
702540003
Referral for spirometry reversibility test
767906009
Post bronchodilator spirometry
774951000000101
Post bronchodilator spirometry
882591000000103
Referral for spirometry reversibility testing

Peak expiratory flow rate (PEFR) codes (PEFR_COD)

SNOMED code

SNOMED code description

1084021000000103Number of consecutive days at less than 80% peak expiratory flow rate (observable entity)
134432000
Recorded/predicted peak expiratory flow rate ratio (observable entity)
165871000000103
Peak expiratory flow rate measured using EN 13826 device (observable entity)
18491006
Peak expiratory flow rate (observable entity)
251936000
Best ever peak expiratory flow rate (observable entity)
251939007
Single peak expiratory flow rate (observable entity)
251940009
Serial peak expiratory flow rate (observable entity)
271507006
Peak flow rate after bronchodilation (observable entity)
271529005
Peak flow rate before bronchodilation (observable entity)
29893006
Peak expiratory flow measurement (procedure)
313232000
Peak expiratory flow rate after bronchodilation (observable entity)
313276007
Peak expiratory flow rate before bronchodilation (observable entity)
37494006
Increased peak expiratory flow rate (finding)
401004000
Peak expiratory flow rate monitoring (regime/therapy)
401011001
Peak expiratory flow rate monitoring using diary (regime/therapy)
401014009
Peak expiratory flow rate pre steroids (observable entity)
401015005
Peak expiratory flow rate post steroids (observable entity)
401163005
Percentage of best ever peak expiratory flow rate (observable entity)
401199000
Percentage of peak expiratory flow rate variability (observable entity)
407668008
Serial peak expiratory flow rate abnormal (finding)
414883002
Number of consecutive days at less than 80 percent peak expiratory flow rate (finding)
429745009
Diurnal variation of peak expiratory flow rate (observable entity)
716760001
Assessment using European Union Scale for Peak Expiratory Flow Rate for adults (procedure)
716761002
Assessment using European Union Scale for Peak Expiratory Flow Rate for children (procedure)
7206008
Decreased peak expiratory flow rate (finding)
763131000000100
Peak expiratory flow rate after exercise (observable entity)
878870000
Peak expiratory flow rate after exercise (observable entity)
980161000000106
European Union Scale for Peak Expiratory Flow Rate - Adult (observable entity)
980181000000102
European Union Scale for Peak Expiratory Flow Rate - Children (observable entity)

Diagnostic Spirometry unavailable codes (SPIRPCASU_COD)

SNOMED code

SNOMED code description

1109901000000102

Diagnostic spirometry quality indicator service unavailable codes

    Codes for asthma quality indicator care unsuitable for patient (ASTPCAPU_COD)

    SNOMED code

    SNOMED code description

    717291000000103

    Excepted from asthma quality indicators - patient unsuitable

    Patients who have chosen not to receive any asthma quality indicator care (ASTPCADEC_COD)

    SNOMED code

    SNOMED code description

    716491000000100

    Excepted from asthma quality indicators - informed dissent

    Patients who have been invited twice for an asthma review at least 7 days apart (ASTINVITE_COD)

    SNOMED code

    SNOMED code description

    1110841000000103

    Quality and Outcomes Framework asthma quality indicator-related care invitation

    185731000
    Asthma monitoring call first letter
    185732007
    Asthma monitoring call second letter 
    185734008
    Asthma monitoring call third letter
    185735009
    Asthma monitoring call verbal invite
    185736005
    Asthma monitoring call telephone invite
    92161000000104
    Quality and Outcomes Framework asthma quality indicator-related care invitation using preferred method of communication
    928451000000107
    Asthma monitoring invitation short message service text message
    928511000000107
    Asthma monitoring invitation email
    959401000000101
    Asthma monitoring short message service text message first invitation
    959421000000105
    Asthma monitoring short message service text message second invitation
    959441000000103
    Asthma monitoring short message service text message third invitation

    Codes indicating the patient has chosen not to receive asthma monitoring (ASTMONDEC_COD)

    SNOMED code

    SNOMED code description

    763221007

    Asthma monitoring declined


      • Related Articles

      • AST011 - Newly diagnosed asthma with tests

        The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF). The codes referenced in this article are taken from the NHS Technology Reference Update Distribution (TRUD). Not all of ...
      • Diagnosing Asthma

        Introduction This article will support you with diagnosing patients with Asthma. It will describe to you the contractual requirements for doing so as well as signposting to useful national guidance which can help. PCIT have included both NICE and ...
      • AST007 - Asthma annual review

        The codes referenced in this article are taken from the NHS Technology Reference Update Distribution (TRUD). Not all of these may be present or selectable in all clinical systems. The information contained within this article is from version 50 of ...
      • AST008 - Asthma smoking status

        The codes referenced in this article are taken from the NHS Technology Reference Update Distribution (TRUD). Not all of these may be present or selectable in all clinical systems. The information contained within this article is from version 50 of ...
      • AST005 - Asthma register

        The codes referenced in this article are taken from the NHS Technology Reference Update Distribution (TRUD). Not all of these may be present or selectable in all clinical systems. The information contained within this article is from version 50 of ...